[HTML][HTML] A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics
Neurodegenerative disorders are primarily characterized by neuron loss. The most common
neurodegenerative disorders include Alzheimer's and Parkinson's disease. Although there …
neurodegenerative disorders include Alzheimer's and Parkinson's disease. Although there …
[HTML][HTML] Advances in developing therapeutic strategies for Alzheimer's disease
Alzheimer's disease (AD) is a progressive deterioration of brain function, initially
characterized by cognitive deficits, with loss of recent memory and language ability …
characterized by cognitive deficits, with loss of recent memory and language ability …
Nanotechnological applications for the treatment of neurodegenerative disorders
G Modi, V Pillay, YE Choonara, VMK Ndesendo… - Progress in …, 2009 - Elsevier
Nanotechnology employs engineered materials or devices that interact with biological
systems at a molecular level and could revolutionize the treatment of neurodegenerative …
systems at a molecular level and could revolutionize the treatment of neurodegenerative …
[HTML][HTML] Nanotechnology-based drug delivery for central nervous system disorders
Drug delivery to central nervous system (CNS) diseases is very challenging since the
presence of the innate blood–brain barrier (BBB) and the blood-cerebrospinal fluid barrier …
presence of the innate blood–brain barrier (BBB) and the blood-cerebrospinal fluid barrier …
[HTML][HTML] Nanoparticle-guided brain drug delivery: Expanding the therapeutic approach to neurodegenerative diseases
C Riccardi, F Napolitano, D Montesarchio, S Sampaolo… - Pharmaceutics, 2021 - mdpi.com
Neurodegenerative diseases (NDs) represent a heterogeneous group of aging-related
disorders featured by progressive impairment of motor and/or cognitive functions, often …
disorders featured by progressive impairment of motor and/or cognitive functions, often …
[HTML][HTML] Nanomedicine: A Promising way to manage Alzheimer's disease
Alzheimer's disease (AD) is a devastating disease of the aging population characterized by
the progressive and slow brain decay due to the formation of extracellular plaques in the …
the progressive and slow brain decay due to the formation of extracellular plaques in the …
Advances in the treatment of neurodegenerative disorders employing nanotechnology
G Modi, V Pillay, YE Choonara - … of the New York Academy of …, 2010 - Wiley Online Library
Due to limitations posed by the restrictive blood–brain barrier, conventional drug delivery
systems do not provide adequate cyto‐architecture restoration and connection patterns that …
systems do not provide adequate cyto‐architecture restoration and connection patterns that …
Advances in the treatment of neurodegenerative disorders employing nanoparticles
C Spuch, O Saida, C Navarro - Recent patents on drug delivery …, 2012 - ingentaconnect.com
Nanoparticles could potentially revolutionise treatment for neurodegenerative diseases such
as Alzheimer's disease (AD), Parkinson's disease (PD) and strokes. Nanotechnologies hold …
as Alzheimer's disease (AD), Parkinson's disease (PD) and strokes. Nanotechnologies hold …
Neurological disorders and therapeutics targeted to surmount the blood–brain barrier
We are now in an aging population, so neurological disorders, particularly the
neurodegenerative diseases, are becoming more prevalent in society. As per the …
neurodegenerative diseases, are becoming more prevalent in society. As per the …
[HTML][HTML] Therapeutic nanoplatforms and delivery strategies for neurological disorders
The major neurological disorders found in a central nervous system (CNS), such as brain
tumors, Alzheimer's diseases, Parkinson's diseases, and Huntington's disease, have led to …
tumors, Alzheimer's diseases, Parkinson's diseases, and Huntington's disease, have led to …